We were excited to announce $11 million raised in our funding round led by Merck's strategic digital health fund this week. CNBC covered the news:
"Drug companies need better ways to recruit patients for their clinical trials, an undertaking that costs millions of dollars today.
Dozens of technology start-ups have popped up to solve this problem.
One start-up in this group is Antidote.me, which today raised $11 million in a round led by Merck's strategic digital health fund. Existing investors Smedvig Capital and Octopus Ventures also participated in the round."
Read more on CNBC.
